HomeBFRIW • NASDAQ
add
Biofrontera
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 7.02M | 2.68% |
Operating expense | 4.83M | 12.75% |
Net income | -3.14M | 38.45% |
Net profit margin | -44.78 | 40.05% |
Earnings per share | — | — |
EBITDA | 988.75K | -35.38% |
Effective tax rate | -28.47% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.10M | — |
Total assets | 24.02M | — |
Total liabilities | 10.13M | — |
Total equity | 13.89M | — |
Shares outstanding | 63.81M | — |
Price to book | 0.27 | — |
Return on assets | 9.13% | — |
Return on capital | 14.07% | — |
Cash Flow
Net change in cash
(EUR) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -3.14M | 38.45% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1997
Website
Employees
92